Location · Philadelphia, PA
Clinical trials in Philadelphia, PA
627 recruiting studies have a site in the Philadelphia area, and 202 of them accept healthy volunteers. The area includes Upland, Bryn Mawr, Wynnewood, Abington, Norristown, Media and nearby cities.
627 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
Vertex Pharmaceuticals Incorporated
- Location
- Philadelphia, PA + 2 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion
Kuros Biosurgery AG
- Location
- Irvine, CA + 5 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
Vektor Medical
- Location
- Jonesboro, AR + 9 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 3
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Neurocrine Biosciences
- Location
- Bryant, AR + 20 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
Amgen
- Location
- Los Angeles, CA + 4 other US sites
- Eligibility basics
- Ages 0 mo–18
- RecruitingPhase 1/Phase 2
Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) and Non-interventional Arm With Untreated Patients
Opus Genetics, Inc
- Location
- Philadelphia, PA + 1 other US site
- Eligibility basics
- Ages 4+
- RecruitingPhase 3
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
Halozyme Therapeutics
- Location
- Los Angeles, CA + 19 other US sites
- Eligibility basics
- Ages 12–17 · Men only
- RecruitingPhase 3
Tissue Repair Gel in Venous Leg Ulcers (US)
TR Therapeutics
- Location
- Castro Valley, CA + 23 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
Rhythm Pharmaceuticals, Inc.
- Location
- Birmingham, AL + 7 other US sites
- Eligibility basics
- Ages 4+
- RecruitingPhase 2
A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder
VistaGen Therapeutics, Inc.
- Location
- Sherman Oaks, CA + 6 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
Dimerix Bioscience Pty Ltd
- Location
- Phoenix, AZ + 19 other US sites
- Eligibility basics
- Ages 12–80
- RecruitingPhase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Sun Pharmaceutical Industries, Inc.
- Location
- Birmingham, AL + 53 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 2
A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
Rapport Therapeutics Inc.
- Location
- Boise, ID + 6 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 1/Phase 2
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
ModernaTX, Inc.
- Location
- Los Angeles, CA + 7 other US sites
- Eligibility basics
- Any age listed
- Recruiting
The Neuralert Stroke Monitor Pilot Trial
Neuralert Technologies LLC
- Location
- Philadelphia, PA
- Eligibility basics
- Ages 22+
- RecruitingPhase 3
Randomized Withdrawal Study in Patients With Schizophrenia
Vanda Pharmaceuticals
- Location
- Rogers, AR + 21 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
Concept Medical Inc.
- Location
- Scottsdale, AZ + 24 other US sites
- Eligibility basics
- Ages 21+
- Recruiting
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
Edwards Lifesciences
- Location
- Huntsville, AL + 49 other US sites
- Eligibility basics
- Ages 65+
- RecruitingPhase 1
Orbit Study: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Intrathecally Administered ION356 in Participants With Pelizaeus Merzbacher Disease (PMD)
Ionis Pharmaceuticals, Inc.
- Location
- Atlanta, GA + 2 other US sites
- Eligibility basics
- Ages 2–17 · Men only
- RecruitingPhase 2
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
InSilico Medicine Hong Kong Limited
- Location
- Birmingham, AL + 11 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
Mezzion Pharma Co. Ltd
- Location
- Phoenix, AZ + 34 other US sites
- Eligibility basics
- Ages 12–18
- Recruiting
Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (REDEFINE)
W.L.Gore & Associates
- Location
- Scottsdale, AZ + 15 other US sites
- Eligibility basics
- Ages 22+ · Women only
- Recruiting
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
Endospan Ltd.
- Location
- Birmingham, AL + 23 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Kartos Therapeutics, Inc.
- Location
- Birmingham, AL + 57 other US sites
- Eligibility basics
- Ages 18+